Actinium Pharmaceuticals, Inc.
ATNM
$1.26
$0.1614.55%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.39% | 15.44% | 3.72% | 2.02% | 21.66% |
| Total Depreciation and Amortization | 1.23% | 1.61% | 1.37% | -2.91% | 2.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 73.66% | 107.00% | 152.41% | 202.53% | 37.74% |
| Change in Net Operating Assets | 24.46% | -683.33% | -163.90% | -176.30% | 70.40% |
| Cash from Operations | 25.68% | 28.06% | 9.63% | 16.05% | 30.13% |
| Capital Expenditure | -845.45% | 100.00% | 100.00% | 100.00% | 92.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -845.45% | 100.00% | 100.00% | 100.00% | 92.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.11% | -12.50% | -28.57% | -80.00% | -125.00% |
| Issuance of Common Stock | -- | -- | -84.00% | -49.57% | 97.20% |
| Repurchase of Common Stock | -20,600.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.74% | -100.71% | -84.03% | -49.59% | 97.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -561.75% | -486.60% | -399.20% | -72.51% | 88.47% |